“I can tell you; this will be blowing the minds of people. I have never come across a model like this in the sector.” – Raman Sehgal, podcast host
May 5, 2023
Culture customers can run large-scale full factorial DOEs and achieve high-quality results quickly and without the need to invest into additional staffing or lab infrastructure
April 4, 2023
A case study of a pharmaceutical client who supplemented in-house capacity with Culture's...
November 24, 2022
The recent increase in consumer demand for sustainably made products has led to a surge in the...
January 21, 2022
Joyn Bio is engineering microbes for sustainable agriculture. Joyn’s Head of Bioprocessing Kelly...
March 5, 2021
Culture's client Nektar Therapeutics is exploring new PEG-based modifications to therapeutic...
October 27, 2020
Is COVID-19 affecting your lab operations? Run bioprocess experiments from...
October 5, 2020
Modern Meadow, one of Culture Biosciences’ first customers, is biomanufacturing the next generation...
September 30, 2020
We spoke with Stefan De Kok, PhD, Director of Fermentation at Zymergen, about his experience...
June 10, 2020
What could you achieve with more bioreactor capacity?You’re no longer limited by the bioreactor capacity in your lab.
.svg)
.png)
